We are working carefully with these CML professionals and anticipate that trial will confirm the results seen with ponatinib inside our ongoing Stage 1 and pivotal Stage 2 trials of ponatinib. .. ARIAD initiates multi-center ponatinib Phase 1/2 clinical trial for CML in Japan ARIAD Pharmaceuticals, Inc. today announced the initiation of a multi-center Phase 1/2 scientific trial in Japan of ponatinib, the Company’s investigational BCR-ABL inhibitor. The trial is being conducted in Japanese individuals with persistent myeloid leukemia who have failed treatment with dasatinib or nilotinib or with Philadelphia-chromosome positive acute lymphoblastic leukemia who have failed prior tyrosine kinase inhibitors.Now, I am looking for excuses to walk and down the stairs up. 7. Get a step buddy. My wife and I agreed to take a 30-minute walk each night also. We hold each other accountable and miss rarely. Find a walking buddy! 8. Publicize your goal. I show everyone I can about my step goals. I wish to create a little pressure plus some support for my attempts. That’s where the Punch Failure in the true face group came in useful. It’s free of charge. People post their daily goals, get support and use a nifty little system for getting rid of excuses and self-sabotage through the full day time. Join us. 9. Arranged a reminder alarm. Arranged a reminder to set off once an hour. Require yourself to get up and move for a couple minutes when it will go off.